Diagnostic efficacy of an optimized nucleotide MALDI-TOF–MS assay for anti-tuberculosis drug resistance detection-Reference-Cited by-同舟云学术

Diagnostic efficacy of an optimized nucleotide MALDI-TOF–MS assay for anti-tuberculosis drug resistance detection

Published:2023-11-18 Issue:1 Volume:43 Page:105-114
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Ou Xichao,Song Zexuan,Zhao Bing,Pei Shaojun,Teng Chong,Zheng Huiwen,He Wencong,Xing Ruida,Wang Yiting,Wang Shengfen,Xia Hui,Zhou Yang,He Ping,Zhao Yanlin

Funder

National Key Research and Development Program of China

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-023-04700-y.pdf

Reference28 articles.

1. World Health Organization (2022) Global tuberculosis report 2022. Geneva. https://iris.who.int/bitstream/handle/10665/363752/9789240061729-eng.pdf. Accessed 27 Oct 2022

2. Dheda K, Limberis JD, Pietersen E, Phelan J, Esmail A, Lesosky M, Fennelly KP, Te Riele J, Mastrapa B, Streicher EM, Dolby T, Abdallah AM, Ben-Rached F, Simpson J, Smith L, Gumbo T, van Helden P, Sirgel FA, McNerney R, Theron G, Pain A, Clark TG, Warren RM (2017) Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir Med 5:269–281. https://doi.org/10.1016/S2213-2600(16)30433-7

3. Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW (2018) Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J Infect 77:469–478. https://doi.org/10.1016/j.jinf.2018.10.004

4. Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A (2018) Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis 18:e199–e210. https://doi.org/10.1016/S1473-3099(18)30111-7

5. Heyckendorf J, Georghiou SB, Frahm N, Heinrich N, Kontsevaya I, Reimann M, Holtzman D, Imperial M, Cirillo DM, Gillespie SH, Ruhwald M, UNITE4TB Consortium (2022) Tuberculosis treatment monitoring and outcome measures New interest and new strategies. Clin Microbiol Rev 35:e0022721. https://doi.org/10.1128/cmr.00227-21